Registro:

Referencias:

• Strand, V., Talal, N., Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy) (1980) Bull Rheum Dis, 92, pp. 212-226
• Jacobsson, L.T.H., Manthorpe, R., Epidemiology of Sjögren's syndrome (1995) Rheumatol Eur, 24, pp. 46-47
• Fox, R.I., Michelson, P., Approaches to the treatment of Sjögren's syndrome (2000) J Rheumatol, 27, pp. 15-21
• Manoussakis, M.N., Moutsopoulos, H.M., Sjögren's syndrome, autoimmune epithelitis (2000) Bailliere's Clin Rheumatol, 14, pp. 72-95
• van Blokland, S.C.A., Versnel, M.A., Pathogenesis of Sögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy (2002) Clin Immunol, 103, pp. 111-124
• Kong, L., Robinson, C.P., Peck, A.B., Vela-Roch, N., Sakata, K.M., Dang, H., Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice (1998) Clin Exp Rheumatol, 16, pp. 675-681
• Robinson, C.P., Yamamoto, H., Peck, A.B., Humphreys-Beher, M.G., Genetically programmed development of salivary gland abnormalities in the NOD-scid mouse: a potential trigger for sialoadenitis of NOD mice (1996) Clin Immunol Immunopathol, 79, pp. 50-59
• Rosignoli, F., Goren, N., Perez Leiros, C., Alterations in the activity and expression of nitric oxide synthase in submandibular glands of NOD mice (2001) Clin Immunol, 101, pp. 86-93
• Rosignoli, F., Perez Leiros, C., Nitric oxide synthase I and VIP-activated signaling are affected in salivary glands of NOD mice (2002) J Neuroimmunol, 130, pp. 109-116
• Rosignoli, F., Roca, V., Meiss, R., Pregi, N., Pérez Leirós, C., Inhibition of calcium-calmodulin kinase restores nitric oxide production and signaling in submandibular glands of a mouse model of salivary dysfunction (2004) Br J Pharmacol, 143, pp. 1058-1065
• Rosignoli, F., Roca, V., Meiss, R., Leceta, J., Gomariz, R.P., Pérez Leirós, C., Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis (2005) Clin Exp Immunol, 142, pp. 411-418
• Ekström, J., Mansson, B., Tobin, G., Vasoactive intestinal peptide evokes secretion of fluid and protein from rat salivary glands and the development of supersensitivity (1983) Acta Physiol Scand, 119, pp. 169-175
• Inoue, Y., Kaku, K., Kaneko, T., Yanahara, N., Kanno, T., Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by cyclic adenosine 3′-5′-monophosphate (1985) Endocrinology, 116, pp. 686-692
• Gomariz, R.P., Juarranz, Y., Abad, C., Arranz, A., Leceta, J., Martinez, C., VIP-PACAP system in immunity: new insights for multitarget therapy (2006) Ann N Y Acad Sci, 1070, pp. 51-74
• Delgado, M., Pozo, D., Ganea, D., The significance of vasoactive intestinal peptide in immunomodulation (2004) Pharmacol Rev, 56 (2), pp. 249-290
• Delgado, M., Munoz-Elias, E.J., Gomariz, R.P., Ganea, D., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies (1999) J Immunol, 162, pp. 1707-1716
• Abad, C., Martinez, C., Juarranz, M.G., Arranz, A., Leceta, J., Delgado, M., Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease (2003) Gastroenterology, 124, pp. 961-971
• Delgado, M., Abad, C., Martinez, C., Leceta, J., Gomariz, R.P., Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease (2001) Nat Med, 7, pp. 563-568
• Rosignoli, F., Torroba, M., Juarranz, Y., Garcia-Gomez, M., Martinez, C., Gomariz, R.P., VIP and tolerance induction in autoimmunity (2006) Ann N Y Acad Sci, 1070, pp. 525-530
• Herrera, J.L., Fernandez-Montesinos, R., Gonzalez-Rey, E., Delgado, M., Pozo, D., Protective role for plasmid DNA-mediated VIP gene transfer in non-obese diabetic mice (2006) Ann N Y Acad Sci, 1070, pp. 337-341
• Petrera, C., Coto, E., Effect of meliacine, a plant derived antiviral, on tumor necrosis factor alpha (2003) Fitoterapia, 74, pp. 77-83
• Ding, A.H., Nathan, C.F., Stuehr, D.J., Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production (1988) J Immunol, 141, pp. 2404-2412
• Roca, V., Larocca, L., Calafat, M., Aisemberg, J., Meiss, R., Franchi, A., Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of NOD mice (2006) Reproduction, 132, pp. 931-938
• O Brien, B.A., Huang, Y., Geng, X., Dutz, J.P., Finegood, D.T., Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced (2002) Diabetes, 51, pp. 2481-2488
• Soffels, K., Overbergh, L., Giulietti, A., Kasran, A., Bouillon, R., Gysemans, C., NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells (2004) J Autoimmun, 23, pp. 9-15
• Gutierrez-Canas, I., Juarranz, Y., Santiago, B., Arranz, A., Martinez, C., Galindo, M., VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts (2006) Rheumatology (Oxford), 45, pp. 527-532
• Cheon, H.J., Rho, Y.H., Choi, S.J., Lee, Y.H., Song, G.G., Sohn, J., Prostaglandin E2 augments IL-10 signaling and function (2006) J Immunol, 177, pp. 1092-1100
• Tetsuka, T., Daphna-Iken, D., Srivastava, S.K., Baier, L.D., DuMaine, J., Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1 (1994) Proc Natl Acad Sci USA, 91, pp. 12168-12172
• Moore, K.W., de Waal Malefyt, R., Coffman, R.L., O'Garra, A., Interleukin-10 and the interleukin-10 receptor (2001) Annu Rev Immunol, 19, pp. 683-765
• Pennline, K.J., Roque-Gaffney, E., Monahan, M., Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse (1994) Clin Immunol Immunopathol, 71, pp. 169-175
• Goldman, M., Marchant, A., Schandene, L., Endogenous interleukin-10 in inflammatory disorders: regulatory roles and pharmacological modulation (1996) Ann NY Acad Sci, 796, pp. 282-292
• Lodde, B.M., Mineshiba, F., Wang, J., Cotrim, A.P., Afione, S., Tak, P.P., Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjögren's syndrome (2006) Ann Rheum Dis, 65, pp. 195-200

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------